Diagnosis and Treatment ofListeria monocytogenesEndophthalmitis: A Systematic Review
Year: 2017
Type: review
Study design: Systematic Review
Abstract: PURPOSE: Describe patient characteristics, treatment, and vision outcomes of Listeria monocytogenes endophthalmitis, an exceedingly rare form of listeriosis. METHODS: L. monocytogenes endophthalmitis cases in human adults, located through Medline (32) and from disease surveillance centers (11). L. monocytogenes conjunctivitis and keratitis were excluded. RESULTS: Most cases occurred in 2000-2015 (22/43), and almost all in Europe or North America (40/43). Patients were a median 61 years, 57% male (24/42) and half were immunosuppressed. Median days from entering care to diagnosis was 8 (IQR = 5-17). Only four were exogenous infections. L. monocytogenes was identified in 31/35 of anterior eye fluid samples (89%). Antibiotic regimens varied markedly (mostly ≥3 drugs). At diagnosis, most were blind in the affected eye (85%, 28/33), only a third regained normal vision (12/36). Older patients had poorer outcomes. CONCLUSIONS: Cases increased over time. Diagnostic delays were common and visual impairment often refractory to treatment, especially in older adults. The condition's rarity and variation in treatment makes it difficult to identify optimum therapy.
Institutions: University of the Witwatersrand, European Centre for Disease Prevention and Control, Hôpital Necker-Enfants Malades, Inserm, Institut Pasteur, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Biology of Infection, Institut des Maladies Génétiques Imagine, Université Paris Descartes, Chris Hani Baragwanath Hospital, Public Health England, NHS Ayrshire and Arran, National Institute for Public Health and the Environment, Landstinget i Kalmar län, University of Parma, Burnet Institute, Monash University
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2585870419